Four investment groups with ties to the family that owns about 35% of Grifols SA confirmed they are in talks with Brookfield ...

MADRID (Reuters) -Shares in Grifols jumped sharply on Wednesday morning after news website El Confidencial reported that ...

Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at ...

Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website El Confidencial that it was ...

Westbourne River Partners letter to Biotest AG with respect to the delisting offer made by Grifols SA to shareholders of Biotest.

Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company ...

The Grifols family has held "very preliminary talks" through several investment firms over a potential takeover bid, according to a source close to the pharmaceutical company's reference shareholders.

Pursuant to the provisions of Article 227 of Law 6/2023 of March 17, on Securities Markets and Investment Services, Grifols (GRFS), S.A. hereby ...

A private clinic that pays up to $100 for plasma donations has opened in Hamilton despite an attempt by city councillors to ...

Grifols and Brookfield said they aren't in takeover talks, after a media report indicated the investment company had resumed discussions with the Grifols family--which controls the Spanish ...

Shares in Grifols surged on Wednesday following a report that Canadian investment firm Brookfield had resumed takeover discussions with the Spanish pharmaceutical company.

Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG: Delisting agreement and announced delisting tender offer eieich, March 31, 2025: Biotest AG (ISIN ...